{
  "id": 2411774,
  "title": "How loss of tumor suppressor drives ER+ breast cancer to metastasize to the bone",
  "url": "https://urgent.news/2026/08/21/how-loss-of-tumor-suppressor-drives-er-breast-cancer-to-metastasize",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T17:40:09.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-loss-tumor-suppressor-er-breast.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells' preference to metastasize to bone.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}